Incremental value of speckle tracking echocardiography to predict Cardiac Resynchronization Therapy (CRT) responders

Journal of the American Heart Association

Volumn 5, Issue 10, 2016, Pages

  Seo, Yoshihiro ^a   Ishizu, Tomoko ^a   Machino Ohtsuka, Tomoko ^a   Yamamoto, Masayoshi ^a   Machino, Takeshi ^a   Kuroki, Kenji ^a   Yamasaki, Hiro ^a   Sekiguchi, Yukio ^a   Nogami, Akihiko ^a   Aonuma, Kazutaka ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Cardiac resynchronization therapy; Heart failure; Speckle training echocardiography; Statistics

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE;

AGED; AREA UNDER THE CURVE; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR DISEASE ASSESSMENT; CARDIOVASCULAR PARAMETERS; CONGESTIVE CARDIOMYOPATHY; CREATININE BLOOD LEVEL; FEMALE; HEART FAILURE; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HUMAN; LEFT ATRIAL VOLUME INDEX; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL COMPUTING; MITRAL REGURGITATION INDEX; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QRS INTERVAL; QUANTITATIVE ANALYSIS; SPECKLE TRACKING ECHOCARDIOGRAPHY; UREA NITROGEN BLOOD LEVEL; COMPLICATION; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; FEASIBILITY STUDY; HEART BUNDLE BRANCH BLOCK; HEART STROKE VOLUME; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PROGNOSIS; STATISTICAL MODEL; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BUNDLE-BRANCH BLOCK; CARDIAC RESYNCHRONIZATION THERAPY; ECHOCARDIOGRAPHY; FEASIBILITY STUDIES; FEMALE; HEART FAILURE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROSPECTIVE STUDIES; STROKE VOLUME; TREATMENT OUTCOME;

EID: 84994475192     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.116.003882     Document Type: Article

References (24)

1. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM; Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140-2150.
2. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L; Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539-1549.
3. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes NA III, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W; MADIT-CRT Trial Investigators. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med. 2009;361:1329-1338.
4. Chung ES, Leon AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J, Abraham WT, Ghio S, Leclercq C, Bax JJ, Yu CM, Gorcsan J III, St John Sutton M, De Sutter J, Murillo J. Results of the predictors of response to CRT (PROSPECT) trial. Circulation. 2008;117:2608-2616.
5. Seo Y, Ito H, Nakatani S, Takami M, Naito S, Shiga T, Ando K, Wakayama Y, Aonuma K; J-CRT investigators. The role of echocardiography in predicting responders to cardiac resynchronization therapy. Circ J. 2011;75:1156-1163.
6. Tanaka H, Nesser HJ, Buck T, Oyenuga O, Jánosi RA, Winter S, Saba S, Gorcsan J III. Dyssynchrony by speckle-tracking echocardiography and response to cardiac resynchronization therapy: results of the Speckle Tracking and Resynchronization (STAR) study. Eur Heart J. 2010;31:1690-1700.
7. Khan FZ, Virdee MS, Palmer CR, Pugh PJ, O'Halloran D, Elsik M, Read PA, Begley D, Fynn SP, Dutka DP. Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial. J Am Coll Cardiol. 2012;59:1509-1518.
8. Maruo T, Seo Y, Yamada S, Arita T, Ishizu T, Shiga T, Dohi K, Toide H, Furugen A, Inoue K, Daimon M, Kawai H, Tsuruta H, Nishigami K, Yuda S, Ozawa T, Izumi C, Fumikura Y, Wada Y, Doi M, Okada M, Takenaka K, Aonuma K. The speckle tracking imaging for the assessment of cardiac resynchronization therapy (START) study. Circ J. 2015;79:613-622.
9. Moons KG, de Groot JA, Linnet K, Reitsma JB, Bossuyt PM. Quantifying the added value of a diagnostic test or marker. Clin Chem. 2012;58:1408-1417.
10. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new biomarker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157-172.
11. Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, Pencina MJ, Kattan MW. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology. 2010;21:128-138.
12. Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006;26:565-574.
13. Yamamoto S, Yamazaki S, Shimizu T, Takeshima T, Fukuma S, Yamamoto Y, Tochitani K, Tsuchido Y, Shinohara K, Fukuhara S. Prognostic utility of serum CRP levels in combination with CURB-65 in patients with clinically suspected sepsis: a decision curve analysis. BMJ Open. 2015;5:e007049.
14. Siddiqui MM, Rais-Bahrami S, Turkbey B, George AK, Rothwax J, Shakir N, Okoro C, Raskolnikov D, Parnes HL, Linehan WM, Merino MJ, Simon RM, Choyke PL, Wood BJ, Pinto PA. Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA. 2015;313:390-397.
15. Gorcsan J III, Abraham T, Agler DA, Bax JJ, Derumeaux G, Grimm RA, Martin R, Steinberg JS, Sutton MS, Yu CM; American Society of Echocardiography Dyssynchrony Writing Group. Echocardiography for cardiac resynchronization therapy: recommendations for performance and reporting-a report from the American Society of Echocardiography Dyssynchrony Writing Group endorsed by the Heart Rhythm Society. J Am Soc Echocardiogr. 2008;21:191-213.
16. Goldenberg I, Moss AJ, Hall WJ, Foster E, Goldberger JJ, Santucci P, Shinn T, Solomon S, Steinberg JS, Wilber D, Barsheshet A, McNitt S, Zareba W, Klein H; MADIT-CRT Executive Committee. Predictors of response to cardiac resynchronization therapy in the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT). Circulation. 2011;124:1527-1536.
17. Yamamoto M, Seo Y, Ishizu T, Kawamatsu N, Sato K, Sugano A, Atsumi A, Harimura Y, Machino-Ohtsuka T, Sakamaki F, Aonuma K. Prognostic significance of persistent restrictive filling pattern after cardiac resynchronization therapy. J Echocardiogr. 2015;13:20-26.
18. Park JH, Negishi K, Grimm RA, Popovic Z, Stanton T, Wilkoff BL, Marwick TH. Echocardiographic predictors of reverse remodeling after cardiac resynchronization therapy and subsequent events. Circ Cardiovasc Imaging. 2013;6:864-872.
19. Klein L, Massie BM, Leimberger JD, O'Connor CM, Piña IL, Adams KF Jr, Califf RM, Gheorghiade M; OPTIME-CHF Investigators. Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIMECHF). Circ Heart Fail. 2008;1:25-33.
20. Testani JM, Cappola TP, Brensinger CM, Shannon RP, Kimmel SE. Interaction between loop diuretic-associated mortality and blood urea nitrogen concentration in chronic heart failure. J Am Coll Cardiol. 2011;58:375-382.
21. Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. N Engl J Med. 1999;341:577-585.
22. Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, Rouleau JL, Tendera M, Castaigne A, Roecker EB, Schultz MK, DeMets DL. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 2001;344:1651-1658.
23. Hjalmarson A, Goldstein S, Fagerberg B, Wedel H, Waagstein F, Kjekshus J, Wikstrand J, El AD, Vitovec J, Aldershvile J, Halinen M, Dietz R, Neuhaus KL, Janosi A, Thorgeirsson G, Dunselman PH, Gullestad L, Kuch J, Herlitz J, Rickenbacher P, Ball S, Gottlieb S, Deedwania P. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. JAMA. 2000;283:1295-1302.
24. Miller TD, Askew JW. Net reclassification improvement and integrated discrimination improvement: new standards for evaluating the incremental value of stress imaging for risk assessment. Circ Cardiovasc Imaging. 2013;6:496-498.